Eagle Pharmaceuticals Reports Third Quarter 2021 Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/25/2026
- Nasdaq, S&P end lower as tech stocks fall
- Micron posts record profit as AI memory demand fuels explosive growth
- Brent settles at lowest since before start of Iran war as more tankers exit Hormuz
- All eyes on Micron earnings tonight as sell-off raises stakes for AI memory trade
- Alphabet added to Dow Jones Industrial Average, Verizon dropped
Eagle Pharmaceuticals (EGRX) Misses Q3 EPS by 27c
November 9, 2021 6:51 AM ESTEagle Pharmaceuticals (NASDAQ: EGRX) reported Q3 EPS of $0.56, $0.27 worse than the analyst estimate of $0.83. Revenue for the quarter came in at $39.9 million versus the consensus estimate of $46.4 million.
For earnings history and earnings-related data on Eagle Pharmaceuticals (EGRX) click here.
... More